Obinutuzumab Interactions
There are 178 drugs known to interact with obinutuzumab, along with 5 disease interactions. Of the total drug interactions, 50 are major, and 128 are moderate.
- View all 178 medications that may interact with obinutuzumab
- View obinutuzumab disease interactions (5)
Most frequently checked interactions
View interaction reports for obinutuzumab and the medicines listed below.
- Acidophilus (lactobacillus acidophilus)
- Activated Charcoal (charcoal)
- Adderall XR (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Afrin Original (oxymetazoline nasal)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aleve (naproxen)
- Align (bifidobacterium infantis)
- Alka-Seltzer Plus Cold (acetaminophen / chlorpheniramine / phenylephrine)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- AquADEKs (multivitamin with minerals)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Benadryl (diphenhydramine)
- Coenzyme Q10 (ubiquinone)
- Crestor (rosuvastatin)
- Eliquis (apixaban)
- Flagyl (metronidazole)
- Jardiance (empagliflozin)
- Lexapro (escitalopram)
- Metoprolol Succinate ER (metoprolol)
- Norco (acetaminophen / hydrocodone)
- Paracetamol (acetaminophen)
- Plaquenil (hydroxychloroquine)
- Qvar RediHaler (beclomethasone)
- Retinol (vitamin a topical)
- Solu-Medrol (methylprednisolone)
- Synthroid (levothyroxine)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Obinutuzumab disease interactions
There are 5 disease interactions with obinutuzumab which include:
- Anti-CD20 antibodies – hepatitis B
- Anti-CD20 antibodies – infections
- tumor lysis syndrome
- cardiopulmonary disease
- cytopenias
Report options
QR code containing a link to this page
More about obinutuzumab
- obinutuzumab consumer information
- Compare alternatives
- Reviews (8)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
